Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
7.24
-0.07 (-0.96%)
Jan 28, 2026, 12:52 PM EST - Market open
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $115.77 million as of January 28, 2026. Its market cap has increased by 82.69% in one year.
Market Cap
115.77M
Enterprise Value
131.53M
1-Year Change
82.69%
Ranking
Category
Stock Price
$7.24
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $115.77M, a decrease of -73.48%. That is a compound annual growth rate of -15.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 118.17M | -11.07% |
| Dec 31, 2025 | 132.88M | 109.60% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 126.68M |
| Oncolytics Biotech | 124.82M |
| Artiva Biotherapeutics | 119.04M |
| Adagene | 117.36M |
| Cognition Therapeutics | 116.52M |
| MacroGenics | 116.40M |
| Repare Therapeutics | 114.24M |
| MAIA Biotechnology | 112.88M |